These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3962866)

  • 1. Use of flecainide acetate for refractory junctional tachycardias in children with the Wolff-Parkinson-White syndrome.
    Ward DE; Jones S; Shinebourne EA
    Am J Cardiol; 1986 Apr; 57(10):787-90. PubMed ID: 3962866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of efficacy of flecainide in the Wolff-Parkinson-White syndrome after isoproterenol administration.
    Brembilla-Perrot B; Admant P; Le Helloco A; Pernot C
    Eur Heart J; 1985 Dec; 6(12):1074-8. PubMed ID: 3830711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of flecainide on electrophysiological properties of accessory pathways in the Wolff-Parkinson-White syndrome.
    Neuss H; Buss J; Schlepper M; Berthold R; Mitrović V; Krämer A; Musial WJ
    Eur Heart J; 1983 May; 4(5):347-53. PubMed ID: 6617681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous and oral flecainide on ventricular tachycardia.
    Ward DE; Cheesman M; Dancy M
    Int J Cardiol; 1986 Mar; 10(3):251-62. PubMed ID: 3957470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of flecainide acetate in rapid atrial fibrillation complicating Wolff-Parkinson-White syndrome.
    Kappenberger LJ; Fromer MA; Shenasa M; Gloor HO
    Clin Cardiol; 1985 Jun; 8(6):321-6. PubMed ID: 4006340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term use of flecainide in patients with supraventricular tachycardia.
    Neuss H
    Drugs; 1985; 29 Suppl 4():21-5. PubMed ID: 4006776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of paediatric arrhythmias to intravenous and oral flecainide.
    Wren C; Campbell RW
    Br Heart J; 1987 Feb; 57(2):171-5. PubMed ID: 3101724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of atrial tachycardias with flecainide acetate.
    Creamer JE; Nathan AW; Camm AJ
    Br Heart J; 1985 Feb; 53(2):164-6. PubMed ID: 3966957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
    Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical use of oral flecainide.
    Slama R; LeClercq JF
    Drugs; 1985; 29 Suppl 4():28-9. PubMed ID: 4006778
    [No Abstract]   [Full Text] [Related]  

  • 13. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S; Ricard P
    Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
    Orning OM
    Eur Heart J; 1984 Sep; 5 Suppl B():81-6. PubMed ID: 6437821
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide.
    Goy JJ; Grbic M; Hurni M; Finci L; Maendly R; Duc J; Sigwart U
    Eur Heart J; 1985 Jun; 6(6):518-24. PubMed ID: 4043101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics.
    Perry JC; McQuinn RL; Smith RT; Gothing C; Fredell P; Garson A
    J Am Coll Cardiol; 1989 Jul; 14(1):185-91; discussion 192-3. PubMed ID: 2500470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the use of flecainide acetate in the long-term management of cardiac arrhythmias.
    Wiseman MN; Elstob JE; Camm AJ; Nathan AW
    Pacing Clin Electrophysiol; 1990 Jun; 13(6):767-75. PubMed ID: 1695357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of flecainide in the preventive treatment of tachycardia crisis of Wolff-Parkinson-White syndrome in 4 newborn infants].
    Lupoglazoff JM; Jacqz-Aigrain E; Denjoy I; Casasoprana A
    Arch Fr Pediatr; 1991 Nov; 48(9):627-9. PubMed ID: 1763931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of flecainide in the treatment of symptomatic children with Wolff-Parkinson-White syndrome.
    Núñez F; Ruiz-Granell R; Martínez-Costa C; Morell S; Brines J
    Pediatr Cardiol; 2010 Nov; 31(8):1162-5. PubMed ID: 20717658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS; Lal R; Ruffy R
    Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.